From Strategy to Outcomes: The New Profile of Influence in Value-Based Care

Value-Based Care is no longer a future state. It is a present-day, highly competitive operating reality.

Over the past decade, the industry has shifted from experimentation to adoption. The question is no longer whether it will scale, but who will lead it and what capabilities will define that leadership.

In the fifth year of Pearl Health’s Top 50 Value-Based Care Thinkers report, more than 200 leaders were nominated, the largest and most diverse cohort to date. This growth reflects the expansion of the field itself, with more capital, greater policy complexity, and rising performance expectations.

The most important signal is not the size of the cohort, but what it reveals: influence in Value-Based Care is being redefined.

A More Demanding Definition of Leadership

To assess this year’s nominees, Pearl applied a structured evaluation framework across four dimensions: demonstrated impact, innovation, execution at scale, and narrative influence.

The process combined broad industry input with AI-assisted research. Structured executive briefings were produced for each nominee to ensure consistency and depth. These materials were reviewed by human judges and further refined through a final evaluation by a panel of senior healthcare executives with extensive operational and policy experience.

The goal was not simply to identify visible leaders. The goal was to determine who is materially shaping the trajectory of Value-Based Care and how they are doing it. What emerged is a more demanding definition of leadership.

Outcomes Have Become the Primary Currency

The most consistent signal across nominees is the primacy of outcomes.

Leaders who stand out are not those articulating a vision for Value-Based Care, but those proving its viability across clinical, financial, and operational dimensions. The defining characteristic of this cohort is execution at scale, consistently translating intent into measurable results: lowering total cost of care, improving longitudinal outcomes, and sustaining performance across populations and geographies.

What distinguishes this group is their ability to manage the full stack simultaneously. Clinical models are tightly linked to financial discipline, operational systems are built for repeatability, and data is embedded directly into workflows to inform real-time decisions. The result is performance that begins to resemble infrastructure rather than innovation.

This reflects a broader shift in the market. Earlier phases rewarded participation and experimentation; pilots and isolated successes were enough. That phase has passed. Today, leadership is defined by the ability to deliver outcomes not just once, but predictably and at scale.

Policy Fluency Remains a Structural Advantage

Influence in Value-Based Care continues to be shaped by policy.

Leaders operating at the intersection of federal rulemaking, payment design, and care delivery maintain a structural advantage. The market is not driven by competition alone. It is defined by regulation, refined through model design, and reinforced by incentive structures that determine how risk and reward are distributed.

The direction is increasingly clear: longer-duration models, greater accountability, and stronger alignment between financial incentives and longitudinal outcomes. Influence is now concentrated in how these models are translated into practice, balancing participation with performance and short-term results with long-term sustainability.

Value-Based Care is, by design, a policy-mediated market. What has changed is the expectation of operators. Policy fluency is no longer specialized. It is foundational. Leaders must interpret rulemaking, anticipate shifts, and align strategy ahead of them.

Organizations that treat policy as static will fall behind. Those that engage with it as a dynamic input, continuously adjusting and acting on signals, are better positioned to lead.

Execution Without Narrative Limits Influence

A more subtle divide is emerging between execution and influence.

Many leaders deliver strong results, but fewer translate those results into a clear narrative that resonates across stakeholders. Performance is necessary, but not sufficient to shape perception, attract capital, or influence the market.

The gap is one of translation. Execution generates outcomes, but narrative determines how they are understood and acted upon. Without it, even strong performance remains localized.

The most influential leaders do both. They pair measurable results with clear articulation, simplifying complexity and connecting execution to system-level impact.

As the ecosystem matures, stakeholders are asking not just whether outcomes improve, but how and whether they are repeatable. Leaders who can answer that clearly are more likely to shape investment and policy.

The Infrastructure Layer Is Becoming Decisive

Another shift reflected in this year’s nominees is the growing importance of infrastructure.

Value-Based Care is no longer defined by care model design or contracting alone. It is increasingly shaped by the systems that enable consistent performance at scale, including data, risk stratification, workflows, and operational support.

As the model expands across geographies, provider types, and patient populations, variability becomes the central challenge.. Infrastructure reduces that variability, enabling standardization, adaptability, and repeatability across diverse settings. Without it, performance remains fragmented. With it, performance compounds.

This layer is also where a significant portion of value is now being created and captured. Infrastructure determines how quickly organizations can onboard into risk, how effectively they can manage populations, and how reliably they can translate insight into action at the point of care. It influences not only outcomes, but the speed, cost, and scalability of achieving those outcomes.

It is now a key source of differentiation. Earlier phases rewarded strategy and intent. Today, leadership is defined by the ability to build and operationalize systems that deliver consistent results.

Four Emerging Archetypes of Influence

This year’s nominees reveal four recurring leadership archetypes that are shaping how Value-Based Care is executed and scaled. While roles and organizations vary, patterns of influence are becoming clearer. These archetypes reflect distinct ways leaders translate strategy into outcomes, manage complexity, and drive impact across the system.

The Policy Translator

These leaders bridge regulation and execution. They translate evolving policy into clear, actionable strategy and reduce uncertainty for operators navigating complex and shifting requirements. Their role extends beyond interpretation. They anticipate where models are heading and position their organizations accordingly.

In practice, this means converting policy signals into decisions around risk, contracting, care model design, and operational priorities. They help organizations move with confidence, aligning strategy to the direction of travel while avoiding reactive or fragmented responses.

As Value-Based Care models grow in scope and duration, this capability is becoming more critical. The environment rewards those who can act early and decisively based on informed interpretation. Leaders who can consistently connect policy to execution are increasingly shaping how the model is adopted and scaled.

‍

The Operator

These leaders are defined by execution. They deliver measurable outcomes at scale and demonstrate that Value-Based Care can function as a durable, repeatable economic model across diverse populations and operating environments.

Their impact is rooted in disciplined performance. Clinical, financial, and operational systems are aligned to produce consistent results, not isolated wins. Outcomes are achieved through structured processes, continuous feedback loops, and a focus on reliability under real-world conditions.

This capability is becoming a primary source of influence as the market matures. The ability to deliver results consistently, and to sustain those results over time, is raising the standard for what leadership in Value-Based Care looks like in practice.

‍

The Platform Builder

These leaders build the infrastructure that enables others to succeed. Their focus is on systems, scalability, and repeatability across organizations, creating the foundation required for Value-Based Care to function consistently in practice.

Their impact is often indirect but highly leveraged. Rather than driving outcomes in a single setting, they design the tools, workflows, and operating models that allow many others to perform. This includes data platforms, risk management capabilities, clinical workflow integration, and contracting frameworks that translate strategy into day-to-day execution. By reducing variability and embedding best practices into systems, they enable performance to scale.

As the market matures, this layer is becoming a primary source of advantage. Organizations that invest in strong infrastructure are better positioned to onboard into risk, manage populations effectively, and sustain outcomes over time. Leaders who build and operationalize these capabilities are shaping how Value-Based Care is delivered at scale.

‍

The Hybrid Leader

This is an increasingly important archetype. These leaders combine policy fluency, operational credibility, and narrative influence, allowing them to operate effectively across domains that have historically been siloed.

Their strength lies in integration. They connect regulatory direction to real-world execution, and translate complex operating models into clear, compelling narratives that resonate across stakeholders. This enables them to align incentives, accelerate adoption, and build trust in environments where ambiguity and fragmentation have often slowed progress.

As Value-Based Care matures, this blended capability is becoming a source of disproportionate influence. The leaders who can move seamlessly between policy, execution, and communication are better positioned to shape both strategy and perception. They do not operate within a single lane. They define how the lanes connect, and in doing so, help determine how the model evolves and scales.

‍

The Risk of Optimization Without Transformation

As the field matures, a key risk is emerging: organizations are becoming more effective at optimizing within existing models—improving benchmarks, coding accuracy, and near-term performance. These gains matter, but they operate within the system rather than changing it.

Optimization is not transformation. Incremental improvements can lift results, but they do not reshape care delivery, risk design, or incentives—and over time, gains risk plateauing.  Without deeper change, gains become harder to sustain or scale.

The next phase of Value-Based Care will require leaders who move beyond refinement to redesign, rethinking care models, risk structures, and incentives. The winners will pair operational excellence with system-level change to define the model’s next evolution..

Implications for Health System and Payer Executives

For senior leaders, four implications stand out:

1. Outcomes must be demonstrable and sustained
2. Policy understanding must be embedded in strategic decision-making
3. Narrative capability is essential for influence and alignment
4. Infrastructure investment is becoming a competitive differentiator

Leadership in Value-Based Care now requires strength across all four dimensions. Performance in only one area is no longer sufficient.

LEAD and the Next Phase of Value-Based Care

The introduction of the ACO LEAD model marks a meaningful inflection point in Value-Based Care.

Unlike prior models, LEAD signals CMS’s commitment to long-term, system-level transformation within traditional Medicare. It raises accountability requirements while tightening how organizations structure and manage performance. Flexibility at the individual provider level is reduced, with success increasingly tied to enterprise-wide management of risk and outcomes.

For executives, LEAD is a forward-looking signal of where the market is headed. It reinforces the importance of scale, strong infrastructure, and disciplined execution, shifting focus from local optimization to consistent performance across entire populations.

Success will require deeper integration across clinical, financial, and operational domains, with aligned incentives, embedded data in workflows, and long-horizon performance management. Leaders who can build and coordinate these capabilities will be best positioned for the next phase of Value-Based Care.

A More Competitive Era

This year’s nominee pool reflects a field that has moved beyond emergence into a competitive phase. Participation is up, capital continues to flow, and expectations are higher. Value-Based Care is no longer about early adoption—it’s about delivering results in a demanding environment.

That shift is raising the bar for leadership. Success is no longer participation or alignment, but consistent outcomes, scalable infrastructure, and disciplined execution under real-world constraints. As the field matures, performance gaps are more visible—and differentiation is increasingly earned, not assumed.

The next phase will be defined by leaders who connect outcomes, infrastructure, and narrative: delivering measurable impact, building systems that sustain it, and communicating it in a way that accelerates adoption.

The final Top 50 will be announced on April 28.